-
US households become increasingly strained in diverging economy
-
Four dead men: the cold case that engulfed a Colombian cycling star
-
Super Bowl stars stake claims for Olympic flag football
-
On a roll, Brazilian cinema seizes its moment
-
Rising euro, falling inflation in focus at ECB meeting
-
AI to track icebergs adrift at sea in boon for science
-
Indigenous Brazilians protest Amazon river dredging for grain exports
-
Google's annual revenue tops $400 bn for first time, AI investments rise
-
Last US-Russia nuclear treaty ends in 'grave moment' for world
-
Man City brush aside Newcastle to reach League Cup final
-
Guardiola wants permission for Guehi to play in League Cup final
-
Boxer Khelif reveals 'hormone treatments' before Paris Olympics
-
'Bad Boy,' 'Little Pablo' and Mordisco: the men on a US-Colombia hitlist
-
BHP damages trial over Brazil mine disaster to open in 2027
-
Dallas deals Davis to Wizards in blockbuster NBA trade: report
-
Iran-US talks back on, as Trump warns supreme leader
-
Lens cruise into French Cup quarters, Endrick sends Lyon through
-
No.1 Scheffler excited for Koepka return from LIV Golf
-
Curling quietly kicks off sports programme at 2026 Winter Olympics
-
Undav pokes Stuttgart past Kiel into German Cup semis
-
Germany goalkeeper Ter Stegen to undergo surgery
-
Bezos-led Washington Post announces 'painful' job cuts
-
Iran says US talks are on, as Trump warns supreme leader
-
Gaza health officials say strikes kill 24 after Israel says officer wounded
-
Empress's crown dropped in Louvre heist to be fully restored: museum
-
UK PM says Mandelson 'lied' about Epstein relations
-
Shai to miss NBA All-Star Game with abdominal strain
-
Trump suggests 'softer touch' needed on immigration
-
From 'flop' to Super Bowl favorite: Sam Darnold's second act
-
Man sentenced to life in prison for plotting to kill Trump in 2024
-
Native Americans on high alert over Minneapolis crackdown
-
Dallas deals Davis to Wizards in blockbuster NBA deal: report
-
Russia 'no longer bound' by nuclear arms limits as treaty with US ends
-
Panama hits back after China warns of 'heavy price' in ports row
-
Strike kills guerrillas as US, Colombia agree to target narco bosses
-
Wildfire smoke kills more than 24,000 Americans a year: study
-
Telegram founder slams Spain PM over under-16s social media ban
-
Curling kicks off sports programme at 2026 Winter Olympics
-
Preventative cholera vaccination resumes as global supply swells: WHO
-
Wales' Macleod ready for 'physical battle' against England in Six Nations
-
Xi calls for 'mutual respect' with Trump, hails ties with Putin
-
'All-time great': Maye's ambitions go beyond record Super Bowl bid
-
Shadow over Vonn as Shiffrin, Odermatt headline Olympic skiing
-
US seeks minerals trade zone in rare Trump move with allies
-
Ukraine says Abu Dhabi talks with Russia 'substantive and productive'
-
Brazil mine disaster victims in London to 'demand what is owed'
-
AI-fuelled tech stock selloff rolls on
-
Russia vows to act 'responsibly' as nuclear pact ends with US
-
White says time at Toulon has made him a better Scotland player
-
Washington Post announces 'painful' job cuts
'Synthetic embryo' breakthrough but growing human organs far off
Stem cell scientists say they have created "synthetic embryos" without using sperm, eggs or fertilisation for the first time, but the prospect of using such a technique to grow human organs for transplantation remains distant.
The breakthrough was hailed as a major step forward, though some experts said the result could not fully be considered to be embryos and warned of future ethical considerations.
In research published in the journal Cell this week, scientists at the Weizmann Institute of Science in Israel described mouse stem cells self-assembling into embryo-like structures in the lab.
The research built upon 2018 research that had a bundle of mouse stem cells self-organised into something resembling the beginnings of an embryo -- but with far fewer cells.
The Weizmann team led by Palestinian stem cell scientist Jacob Hanna went much further.
They started by collecting cells from the skin of mice, then made them artificially return to the state of stem cells.
The stem cells were then placed in a special incubator, which continuously moved to mimic a mother's womb.
The vast majority of the cells failed to form anything.
But 50 -- 0.5 percent of the 10,000 total -- collected themselves into spheres, then embryo-like structures, the researchers said.
After eight days -- around a third of the 20-day mouse gestation period -- there were early signs of a brain and a beating heart, they added.
They were described as 95 percent similar to normal mouse embryos.
"The embryo is the best organ-making machine and the best 3D bioprinter -- we tried to emulate what it does," Hanna said in a Weizmann statement.
- 'Not embryos' -
While they were the most advanced synthetic embryo-like structures ever grown, some scientists not involved in the research warned against calling them "embryos".
"These are not embryos," French stem cell scientist Laurent David told AFP.
"Until proven otherwise, they do not result in a viable individual capable of reproducing," he added.
He preferred to call them embryoids, the name for a group of cells that resemble an embryo, emphasising that they showed only the very beginnings of organs.
However, David welcomed the "very convincing" research, which he said could allow further experiments to understand exactly how organs form.
Hanna said the team's "next challenge is to understand how stem cells know what to do -- how they self-assemble into organs and find their way to their assigned spots inside an embryo".
- Ethical implications -
If human organs could one day be grown in a lab, it could provide life-saving transplants to thousands of people every year without the need for donors.
There has been progress in this new field -- several years ago researchers managed to develop an artificial intestine in the lab that could be implanted into a mouse.
For humans, however, such organ implants remain science fiction.
Still, Hanna has founded a company, Renewal Bio, that aims to find a way to use the technology for therapeutic purposes.
Researchers not involved in the study said it was very early to consider using such a technique for humans.
Alfonso Martinez Arias of Spain's Pompeu Fabra University said the breakthrough "opens the door to similar studies with human cells, though there are many regulatory hoops to get through first and, from the point of view of the experiments, human systems lag behind mouse systems".
And aiming to get similar results from human cells will likely open an ethical can of worms.
"Although the prospect of synthetic human embryos is still distant, it will be crucial to engage in wider discussions about the legal and ethical implications of such research," James Briscoe of Britain's Francis Crick Institute said.
E.AbuRizq--SF-PST